An interdisciplinary research team from the University of Hong Kong (HKU), Zhejiang University, and Guangzhou Medical University has introduced an innovative continuous glucose monitoring (CGM) system that has the potential to transform diabetes management. Published in the journal Science Advances, the study showcases the OECT-CGM, a compact device enhanced with advanced biosensors and minimally invasive technology.
Key Features of the OECT-CGM
Under the leadership of Professor Shiming Zhang from HKU’s Department of Electrical and Electronic Engineering, the device utilizes an organic electrochemical transistor (OECT). This technology improves signal quality, ensuring that glucose readings are both accurate and reliable. Additionally, the system includes a microneedle array, enabling painless subcutaneous glucose sampling, which significantly enhances user comfort.
Performance and Future Applications
The performance of the OECT-CGM has been rigorously tested on rodents, demonstrating a level of sensitivity that is on par with existing commercial CGMs available in the market. The research team plans to refine this device further and investigate its potential applications across different healthcare settings.
Commitment to Diabetes Management
This groundbreaking innovation highlights not only a major technological leap in wearable health devices but also underscores HKU’s dedication to enhancing the quality of life for individuals living with diabetes.